Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Xlife Sciences AG
XLSCurrent price
24.80 CHF
-1 CHF (-3.88%)
Last closed
25.80 CHF
Company
www.xlifesciences.ch
ISIN
CH0461929603
Sector
Healthcare
Industry
Biotechnology
Exchange
SIX Swiss Exchange
Capitalization
144 099 726 CHF
Yield for 12 month
-50.30 %
1Y
3Y
5Y
10Y
15Y
XLS
Xlife Sciences AG focuses on the development and commercialization of technologies in the life sciences sector. The company's project consists of technology platforms that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also engages in developing mono-and bispecific anti-tumor antibodies for the treatment of life-threatening diseases; researching, developing, and manufacturing chemical and active pharmaceutical ingredients for human and veterinary medicines; and early identification kidney diseases. Xlife Sciences AG also focuses on functional screening of antibodies by microfluidics-based technologies; and offers Neuromex, a screening instrument for the early-stage detection of neurodegenerative diseases. Xlife Sciences AG was founded in 2019 and is based in Zurich, Switzerland. Address: Talacker 35, Zurich, Switzerland, 8001
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
61.33 CHFP/E ratio
7.67Dividend Yield
–Current Year
+992 294 CHF
Last Year
+1 031 984 CHF
Current Quarter
+349 338 CHF
Last Quarter
+658 079 CHF
Current Year
+450 773 CHF
Last Year
+186 365 CHF
Current Quarter
+123 832 CHF
Last Quarter
+180 151 CHF
Key Figures XLS
1 year
3 years
5 years
10 years
EBITDA
-2 754 136 CHF
Operating Margin TTM
PE Ratio
7.67
Return On Assets TTM
-2.36 %
PEG Ratio
–
Return On Equity TTM
4.47 %
Wall Street Target Price
61.33 CHF
Revenue TTM
994 141 CHF
Book Value
48.02 CHF
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
0.50 %
Dividend Yield
–
Gross Profit TTM
360 522 CHF
Earnings per share
3.27 CHF
Diluted Eps TTM
3.27 CHF
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
-3.70 %
Profit Margin
2 144.50 %
Dividend Analytics XLS
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History XLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation XLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
7.6687
Forward PE
–
Enterprise Value Revenue
200.6662
Price Sales TTM
144.949
Enterprise Value EBITDA
7.2901
Price Book MRQ
0.5261
Financials XLS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators XLS
For 52 weeks
22.59 CHF
51.60 CHF
50 Day MA
26.46 CHF
Shares Short Prior Month
–
200 Day MA
31.81 CHF
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart